Isepamicin once a day : enhancing traditional aminoglycoside therapy. MeetingJournal of chemotherapy. 1995, Vol 7, issn 1120-009X, 173 p., SUP2Conference Proceedings

Once-daily versus multiple-daily dosing of aminoglycosidesCRAIG, W. A.Journal of chemotherapy. 1995, Vol 7, pp 47-52, issn 1120-009X, SUP2Conference Paper

The role of aminoglycosides in modern therapyBEAUCAIRE, G.Journal of chemotherapy. 1995, Vol 7, pp 111-123, issn 1120-009X, SUP2Conference Paper

An overview of the safety of isepamicin in adultsBLUM, D.Journal of chemotherapy. 1995, Vol 7, pp 87-93, issn 1120-009X, SUP2Conference Paper

Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infectionsPETRIKKOS, G; GIAMARELLOU, H; TSAGARAKI, C et al.Journal of chemotherapy. 1995, Vol 7, pp 161-164, issn 1120-009X, SUP2Conference Paper

Isepamicin versus amikacin in the treatment of urinary tract infectionSTURM, W.Journal of chemotherapy. 1995, Vol 7, pp 149-154, issn 1120-009X, SUP2Conference Paper

Pharmacokinetics of isepamicin in paediatric patientsSCAGLIONE, F; VIGANO, A; COLUCCI, R et al.Journal of chemotherapy. 1995, Vol 7, pp 63-69, issn 1120-009X, SUP2Conference Paper

Pharmacokinetics of isepamicinBARR, W. H; COLUCCI, R; RADWANSKI, E et al.Journal of chemotherapy. 1995, Vol 7, pp 53-61, issn 1120-009X, SUP2Conference Paper

A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patientsVIGANO, A; PRINCIPI, N.Journal of chemotherapy. 1995, Vol 7, pp 95-101, issn 1120-009X, SUP2Conference Paper

Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemiaBEAUCAIRE, G.Journal of chemotherapy. 1995, Vol 7, pp 165-173, issn 1120-009X, SUP2Conference Paper

Overview of the efficacy of isepamicin in the adult core clinical trial programmeCARBON, C.Journal of chemotherapy. 1995, Vol 7, pp 79-85, issn 1120-009X, SUP2Conference Paper

Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infectionsRODRIGUEZ-NORIEGA, E; ESPARZA-AHUMADA, S; MORFIN-OTERO, R et al.Journal of chemotherapy. 1995, Vol 7, pp 155-160, issn 1120-009X, SUP2Conference Paper

The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infectionsLEAL DEL ROSAL, P.Journal of chemotherapy. 1995, Vol 7, pp 143-148, issn 1120-009X, SUP2Conference Paper

The most frequently occurring aminoglycoside resistance mechanisms : combined results of surveys in eight regions of the worldJournal of chemotherapy. 1995, Vol 7, pp 17-30, issn 1120-009X, SUP2Conference Paper

Comparaison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by Gram-negative organismsCOVI, M; VELLUTI, G.Journal of chemotherapy. 1995, Vol 7, pp 137-142, issn 1120-009X, SUP2Conference Paper

Isepamicin (SCH 21420, 1-N-HAPA gentamicin B) : microbiological characteristics including antimicrobial potency and spectrum of activityJONES, R. N.Journal of chemotherapy. 1995, Vol 7, pp 7-16, issn 1120-009X, SUP2Conference Paper

Aminosides : une fois par jour ? = Aminoglycosides : once a day?FANTIN, B.La Revue du praticien (Paris). 1998, Vol 48, Num 4, pp 353-355, issn 0035-2640Article

Once-daily aminoglycoside therapyGILBERT, D. N.Antimicrobial agents and chemotherapy. 1991, Vol 35, Num 3, pp 399-405, issn 0066-4804, 7 p.Article

What is the evidence for once-daily aminoglycoside therapy ?BARCLAY, M. L; BEGG, E. J; HICKLING, K. G et al.Clinical pharmacokinetics. 1994, Vol 27, Num 1, pp 32-48, issn 0312-5963Article

Efficacy and safety of aminoglycosides once-a-day : experimental and clinical dataTULKENS, P. M.Scandinavian journal of infectious diseases. Supplementum. 1990, Num 74, pp 249-257, issn 0300-8878, 9 p.Conference Paper

Once-daily aminoglycoside therapy : Potential ototoxicitySINGER, C; SMITH, C; KRIEFF, D et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 9, pp 2209-2211, issn 0066-4804Article

Minoxidil, nadolol, and a diuretic: once-a-day therapy for resistant hypertensionSPITALEWITZ, S; PORUSH, J. G; REISER, I. W et al.Archives of internal medicine (1960). 1986, Vol 146, Num 5, pp 882-886, issn 0003-9926Article

Vestibular toxic effects induced by once-daily aminoglycoside therapyDHANIREDDY, Shireesha; LILES, W. Conrad; GATES, George A et al.Archives of otolaryngology, head & neck surgery. 2005, Vol 131, Num 1, pp 46-48, issn 0886-4470, 3 p.Article

Surgical complications following twice-a-day versus once-a-day radiation therapyMETSON, R; FREEHLING, D. J; WANG, C. C et al.The Laryngoscope. 1988, Vol 98, Num 1, pp 30-34, issn 0023-852XConference Paper

Once-a-day highly active antiretroviral therapy: A systematic reviewENA, Javier; PASQUAU, Francisco.Clinical infectious diseases. 2003, Vol 36, Num 9, pp 1186-1190, issn 1058-4838, 5 p.Article